Saturday, Feb 27, 2021 : Issue #1110

TOP STORIES - Diabetes News & Research

Diabetes, Depression, and Dementia Link

Hyperglycemia & the Link Between Diabetes and COVID-19 Deaths

Medication Burden in Patients with Diabetes

Letter from the Editor

Leyany Feijoo Ramos, PharmD Candidate, LECOM School of Pharmacy, is considering a residency in infectious medicine, which would put her in the forefront of COVID-19 research and treatment. She recently put together an overview of how diabetes and increased glucose levels in non-diagnosed diabetes patients can increase the patients' chances of dying from an infection.

The information she is sharing will make you think twice about giving a patient time to fix their glucose before you begin aggressive therapy.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief

Newsflash: Diabetes + Covid = Increased Risk for DEATH

See this week’s Fact.

Fact: 20% of Diabetes Patients With COVID-19 May Die

A study in Diabetologia found that 20% of patients died within 28 days of being admitted to a hospital. Based on data from roughly 2,800 adults, the findings also revealed that elevated blood glucose level at the time of hospital admission was a strong predictor of lower odds of discharge and a higher risk of death. The patients’ mean age was 70, nearly two-thirds were men, and many were overweight. About 40% were also experiencing various forms of complications from their diabetes. Routine treatment by insulin and statin were cited as deleterious factors, while younger age, routine metformin therapy and longer symptom duration on admission were positively associated with discharge. Of those patients who survived at least one month, 50% were discharged from the hospital with a median stay of nine days; 12% were still hospitalized on day 28, and 17% had been transferred from their first hospital to another facility.

Mangala Narasimhan, Diabetologia, news release, Feb. 17, 2021

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Alexandria Bartley, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences

Eric Cheung, PharmD Candidate, USF Taneja College of Pharmacy

Zahra Hashemy, PharmD. Candidate, USF Taneja College of Pharmacy

Laura Martínez López, PharmD. Candidate 2021, Lake Erie College of Osteopathic Medicine, College of Pharmacy

Leyany Feijoo Ramos, PharmD. Candidate, LECOM School of Pharmacy

Stephen Rubano, PharmD. Candidate, USF Taneja College of Pharmacy

About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.

Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com

Diabetes In Control
2093 Philadelphia Pike #8370
Claymont, DE, 19703, United States

DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe

Saturday, Feb 27, 2021 : Issue #1110

TOP STORIES - Diabetes News & Research

Newsflash: Diabetes + Covid = Increased Risk for DEATH

TOP STORIES - Diabetes News and Research

Fact: 20% of Diabetes Patients With COVID-19 May Die

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters: